Ftse Mib
33.248,24
-1,08%
DAX
18.232,76
-0,17%
S&P 500
5.433,74
0,23%
NASDAQ
17.667,56
0,34%
Bitcoin
66.843,32
0,13%
Registration Strip Icon for charts Registrati per grafici in tempo reale, strumenti di analisi e prezzi.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Molecular Partners AG (MOLN) Molecular Partners AG (MOLN) Notizie

Molecular Partners AG

MOLN
5,95
0,00 (0,00%)
14 Giu 2024 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Ricevuta di Deposito
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
14/6/202407:00GLOBEMolecular Partners Presents Positive Preclinical Data for..
11/6/202416:16EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
11/6/202407:00GLOBEMolecular Partners and Orano Med Share Positive Preclinical..
03/6/202423:06EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
01/6/202414:00GLOBEMolecular Partners Presents Positive Data From Completed..
17/5/202412:25EDGAR2Form 6-K/A - Report of foreign issuer [Rules 13a-16 and..
16/5/202422:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
16/5/202422:00GLOBEInterim Management Statement Q1 2024 of Molecular Partners:..
29/4/202417:00GLOBEMolecular Partners Announces Publication in Cancer..
19/4/202417:12GLOBELife Science Cares Launches in Switzerland
17/4/202417:12GLOBEMolecular Partners Announces All Board Proposals Approved at..
26/3/202414:26GLOBEMolecular Partners Publishes Invitation to Annual General..
14/3/202421:00GLOBEMolecular Partners Reports Corporate Highlights From Q4 2023..
01/3/202422:00GLOBEMolecular Partners To Hold Conference Call to Discuss Fourth..
08/1/202418:33EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
07/1/202422:00GLOBEMolecular Partners Provides Updates at 42nd Annual J.P...
05/1/202422:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
05/1/202422:00GLOBEMolecular Partners and Orano Med Announce Co-Development..
14/12/202307:00GLOBEMolecular Partners to Present at 42nd Annual J.P. Morgan..
10/12/202318:00GLOBEMolecular Partners Presents Positive Initial Data from First..
14/11/202307:00GLOBEMolecular Partners to Present on DARPin Oncology Innovations..
03/11/202317:00GLOBEMolecular Partners Presents Updated Positive Data from..
02/11/202311:01EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
02/11/202307:00GLOBEMolecular Partners to Present Initial Data from Ongoing..
01/11/202307:00GLOBEMolecular Partners to Participate in the TD Cowen 7th Annual..
26/10/202322:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
26/10/202322:00GLOBEMolecular Partners Interim Management Statement Q3 2023:..
13/9/202307:00GLOBEMolecular Partners Presents New Data on its Radio DARPin..
24/8/202322:02EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
24/8/202322:00GLOBEMolecular Partners Reports H1 2023 Corporate Highlights and..
28/6/202314:34EDGAR2Form S-8 - Securities to be offered to employees in employee..
27/6/202307:00GLOBEMolecular Partners to Present on its Radio DARPin Therapy..
19/6/202318:00GLOBEMolecular Partners to Present at The TD Cowen..
Apertura: Min: Max:
Chiusura: 5,95

La tua Cronologia

NASDAQ
MOLN
Molecular Partners
BIT
I09218
Intesa Sanpaolo
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network